Taylor & Francis Group
Browse
kaup_a_2341588_sm1555.docx (472.24 kB)

The Wolfram-like variant WFS1E864K destabilizes MAM and compromises autophagy and mitophagy in human and mice

Download (472.24 kB)
journal contribution
posted on 2024-04-23, 11:00 authored by Simone Patergnani, Méghane S. Bataillard, Alberto Danese, Stacy Alves, Chantal Cazevieille, René Valéro, Lisbeth Tranebjærg, Tangui Maurice, Paolo Pinton, Benjamin Delprat, Elodie M. Richard

Dominant variants in WFS1 (wolframin ER transmembrane glycoprotein), the gene coding for a mitochondria-associated endoplasmic reticulum (ER) membrane (MAM) resident protein, have been associated with Wolfram-like syndrome (WLS). In vitro and in vivo, WFS1 loss results in reduced ER to mitochondria calcium (Ca2+) transfer, mitochondrial dysfunction, and enhanced macroautophagy/autophagy and mitophagy. However, in the WLS pathological context, whether the mutant protein triggers the same cellular processes is unknown. Here, we show that in human fibroblasts and murine neuronal cultures the WLS protein WFS1E864K leads to decreases in mitochondria bioenergetics and Ca2+ uptake, deregulation of the mitochondrial quality system mechanisms, and alteration of the autophagic flux. Moreover, in the Wfs1E864K mouse, these alterations are concomitant with a decrease of MAM number. These findings reveal pathophysiological similarities between WS and WLS, highlighting the importance of WFS1 for MAM’s integrity and functionality. It may open new treatment perspectives for patients with WLS.

Abbreviations: BafA1: bafilomycin A1; ER: endoplasmic reticulum; HSPA9/GRP75: heat shock protein family A (Hsp70) member 9; ITPR/IP3R: inositol 1,4,5-trisphosphate receptor; MAM: mitochondria-associated endoplasmic reticulum membrane; MCU: mitochondrial calcium uniporter; MFN2: mitofusin 2; OCR: oxygen consumption rate; ROS: reactive oxygen species; ROT/AA: rotenone+antimycin A; VDAC1: voltage dependent anion channel 1; WLS: Wolfram-like syndrome; WS: Wolfram syndrome; WT: wild-type

Funding

The work was supported by the AFM-Téléthon [Ignition]; Eye Hope Foundation; Fondation Pour l’Audition [RD-2019-13]; Fondation de France; FISM—Fondazione Italiana Sclerosi Multipla—cod.2022/R-Multi/050 and co-financed with the ‘5 per mille’ public funding; A-ROSE (Associazione Ricerca Oncologica Sperimentale Estense); external resources of the University of Montpellier; Agence Nationale pour la Recherche [ANR-12-JSV1-0008-01]; The Snow Foundation; local funds from the University of Ferrara Italian Ministry of Education, University and Research [PRIN, 2017 E5L5P3]; Italian Association for Cancer Research [IG-23670]; Italian Association for Cancer Research [AIRC, 27938]; Italian Association for Cancer Research [AIRC, MFAG-29087]; Retina France.

History

Usage metrics

    Autophagy

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC